This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Daegu-Gyeongbuk Medical Innovation Foundation, Omic Smap Inc., Pimedbio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 10 
1 out of 1 
1 out of 1 Years Active: 2026
Title: Ji Hoon Yu - Innovator in Cancer Treatment
Introduction
Ji Hoon Yu is an inventor based in Daegu, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research. Although he currently holds no granted patents, his work is focused on developing pharmaceutical compositions that target cancer diseases.
Latest Patent Applications
Ji Hoon Yu has filed several patent applications, including:
1. **3,4-Dihydroquinoxaline-2-carboximide Derivative Compound and Pharmaceutical Composition Comprising Same for Preventing or Treating Cancer Disease** - This application relates to a compound that selectively inhibits histone deacetylase (HDAC) 8, making it a potential candidate for cancer treatment.
2. **Quinazoline-2,4-Diamine Derivative and Pharmaceutical Composition for Preventing or Treating Cancer Comprising Same as Active Ingredient** - This application describes a compound that exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), which can be useful in cancer therapy.
Conclusion
Ji Hoon Yu is an emerging inventor whose research focuses on innovative solutions for cancer treatment. His latest patent applications reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile